Cargando…

Identification of microRNAs and genes as biomarkers of atrial fibrillation using a bioinformatics approach

OBJECTIVE: We aimed to explore potential microRNAs (miRNAs) and target genes related to atrial fibrillation (AF). METHODS: Data for microarrays GSE70887 and GSE68475, both of which include AF and control groups, were downloaded from the Gene Expression Omnibus database. Differentially expressed miRN...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yingyuan, Tan, Wulin, Ye, Fang, Xue, Faling, Gao, Shaowei, Huang, Wenqi, Wang, Zhongxing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6726789/
https://www.ncbi.nlm.nih.gov/pubmed/31218935
http://dx.doi.org/10.1177/0300060519852235
Descripción
Sumario:OBJECTIVE: We aimed to explore potential microRNAs (miRNAs) and target genes related to atrial fibrillation (AF). METHODS: Data for microarrays GSE70887 and GSE68475, both of which include AF and control groups, were downloaded from the Gene Expression Omnibus database. Differentially expressed miRNAs between AF and control groups were identified within each microarray, and the intersection of these two sets was obtained. These miRNAs were mapped to target genes in the miRNet database. Functional annotation and enrichment analysis of these target genes was performed in the DAVID database. The protein-protein interaction (PPI) network from the STRING database and the miRNA-target-gene network were merged into a PPI-miRNA network using Cytoscape software. Modules of this network containing miRNAs were detected and further analyzed. RESULTS: Ten differentially expressed miRNAs and 1520 target genes were identified. Three PPI-miRNA modules were constructed, which contained miR-424, miR-15a, miR-542-3p, and miR-421 as well as their target genes, CDK1, CDK6, and CCND3. CONCLUSION: The identified miRNAs and genes may be related to the pathogenesis of AF. Thus, they may be potential biomarkers for diagnosis and targets for treatment of AF.